Dipl.-Kfm. Martin Franz
Partner
+49 (89) 809 53 63- 0
Curriculum vitae & references Quickcontact
ConAlliance provides top-tier M&A advisory services in this dynamic sector of global orthopedics, backed by deep industry expertise and a robust portfolio of successful transactions. With extensive experience in orthopedics, our team ensures a streamlined, results-driven approach to every deal, whether managing due diligence processes or overseeing a full M&A transaction. This depth of experience and our proven track record make us the clear choice for clients seeking precision, efficiency, and superior outcomes in healthcare M&A.
The global orthopedics market, particularly in orthopedic devices, boasts an estimated volume in the mid-double-digit billions USD range, presenting significant upside potential for investors. Projections indicate substantial growth in the forthcoming years. Various ConAlliance analyses forecast robust compound annual growth rates (CAGR), pointing toward a market volume of approximately USD 100 billion by 2034.
The most prominent sub-segment is joint reconstruction and replacement (knee, hip, shoulder), especially via hip and knee endoprostheses, followed by spinal products (spinal implants and instruments). Notably, spinal surgery robotics and navigation have exhibited impressive revenue surges in recent years. The market also encompasses the management of bone fractures through trauma fixation devices such as plates, screws, and pins, as well as arthroscopy, primarily employed in treating tendons and ligaments (e.g., anterior cruciate ligament, meniscus). The orthobiologics sub-market is another critical segment. With the rising popularity of sports and fitness, there's an escalating demand for minimally invasive surgical instruments and devices—such as arthroscopy—for the treatment of sports injuries. Additionally, non-invasive aids like orthopedic braces and orthoses, as well as orthopedic prosthetics, foot and ankle products, hand and wrist products, and rehabilitation devices, are noteworthy sub-segments.
Demographic trends already underscore the high attractiveness of the orthopedics segment and the consequent demand for M&A activities: a significant portion of the European population is over 65 years old—a figure on an upward trajectory. This age structure brings about substantial transformations in healthcare. The uptick in outpatient surgeries reduces the length of inpatient hospital stays, considerably cutting associated costs. Concurrently, a marked increase in the total number of procedures is anticipated, signaling above-average growth in orthopedics and adjacent sectors.
The orthopedics market is a dynamic and burgeoning sector within the medtech industry, where companies endeavor to fortify their market position, diversify their product portfolio, and gain entrée to new technologies and markets through mergers and acquisitions.
In recent years, both major and mid-sized enterprises have executed strategic acquisitions to expand in domains such as joint reconstruction, spinal implants, orthobiologics, and digital health technologies. Catalysts such as technological innovations, an aging populace, and the surging demand for orthopedic treatments are propelling these M&A activities.
Moreover, regulatory shifts and intensifying competition are prompting companies to achieve economies of scale via M&A transactions and amplify their market presence. Private equity firms are also exhibiting a burgeoning interest in investments within this sector, further invigorating M&A activities.
In sum, the orthopedics market is characterized by high dynamism, and M&A transactions play a pivotal role in the strategic orientation and growth of companies in this arena. Historically active strategists like Stryker Corporation, Zimmer Biomet, Johnson & Johnson (DePuy Synthes), Smith & Nephew, Medtronic, and NuVasive are, in our estimation, poised to continue driving consolidation.
ConAlliance possesses comprehensive acumen in the orthopedics market, encompassing current trends, technological innovations, and market players. This savoir-faire enables us to proffer well-founded strategic recommendations and identify potential synergies. Our extensive experience in orthopedics ensures efficient and focused execution, whether in conducting due diligence processes or facilitating M&A transactions. Leveraging our expansive network of key stakeholders in orthopedics—including manufacturers, clinics, investors, and industry experts—we can effectively identify and approach potential acquisition targets or investors.
ConAlliance has a demonstrable track record in executing M&A transactions within the orthopedics sector. Our proficiency in structuring, negotiating, and implementing complex deals significantly contributes to transaction success. Contact us to capitalize on our specialized expertise and actualize your strategic objectives in the orthopedics segment.